Evidence map›Paper›PMID 23108718›Full record

Trial reportPrenatal diagnosis2012

Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci.

Bernhard Zimmermann, Matthew Hill, George Gemelos, Zachary Demko, Milena Banjevic, Johan Baner, Allison Ryan, Styrmir Sigurjonsson, Nikhil Chopra, Michael Dodd and 2 more

Abstract readClinical Trial
In one paragraph

Trial report in Prenatal diagnosis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 3 pooled it
58.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 3 syntheses or guidelines pooled it, 330 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Identifying Strategies to Improve Shared Decision Making for Pregnant Patients' Decisions about Prenatal Genetic Screens and Diagnostic Tests.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Trial
  5. Whole-genome paternal uniparental disomy identified through prenatal single-nucleotide polymorphism-based cell-free DNA screening.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2026
    Article
  6. Article
  7. Article
  8. Advances in laboratory medicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Bernhard ZimmermannNatera Inc, San Carlos, CA, USA.
Matthew Hill
George Gemelos
Zachary Demko
Milena Banjevic
Johan Baner
Allison Ryan
Styrmir Sigurjonsson
Nikhil Chopra
Michael Dodd
Brynn Levy
Matthew Rabinowitz
Natera (United States) · USColumbia University · US

Funding

Non-invasive Aneuploidy Screening of Circulating Fetal Cells for Prenatal DiagnosR44HD062114 · NICHD · NATERA, INC. · PI RABINOWITZ, MATTHEW · 2010 to 2012
$1.8M
NICHD NIH HHS 4R44HD062114-02NICHD NIH HHS R44 HD062114
6 · The paper itself

Abstract

objectiveThis study aims to develop a noninvasive prenatal test on the basis of the analysis of cell-free DNA in maternal blood to detect fetal aneuploidy at chromosomes 13, 18, 21, X, and Y.

methodsA total of 166 samples from pregnant women, including 11 trisomy 21, three trisomy 18, two trisomy 13, two 45,X, and two 47,XXY samples, were analyzed using an informatics-based method. Cell-free DNA from maternal blood was isolated, amplified using a multiplex polymerase chain reaction (PCR) assay targeting 11,000 single nucleotide polymorphisms on chromosomes 13, 18, 21, X, and Y in a single reaction, and sequenced. A Bayesian-based maximum likelihood statistical method was applied to determine the chromosomal count of the five chromosomes interrogated in each sample, along with a sample-specific calculated accuracy for each test result.

resultsThe algorithm correctly reported the chromosome copy number at all five chromosomes in 145 samples that passed a DNA quality test, for a total of 725/725 correct calls. The average calculated accuracy for these samples was 99.92%. Twenty-one samples did not pass the DNA quality test.

conclusionsThis informatics-based method noninvasively detected fetuses with trisomy 13, 18, and 21, 45,X, and 47,XXY with high sample-specific calculated accuracies for each individual chromosome and across all five chromosomes.

Indexed as

Chromosomes, HumanMaternal Serum Screening TestsFemaleHumansKaryotypeMalePregnancySex Chromosome AberrationsSex Chromosome DisordersTrisomy

Identifiers

PMID23108718
PMCPMC3548605
OpenAlexW2129125677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.